BCLI logo

Brainstorm Cell Therapeutics Inc. (BCLI)

Profile

Full Name

Brainstorm Cell Therapeutics Inc.

Ticker

NASDAQ: BCLI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 7, 2003

Indexes

Not included

Website

http://www.brainstorm-cell.com

Employees

29

Key Details

Price

$0.72(-2.70%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.31(+61.50% YoY)

PE ratio

-

Next earnings date

Aug 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.72
    BCLI price is $0.72

    30-Day Relative Volume

    0.79
    BCLI 30-day relative volume is 0.79

    Price Performance

    Price Today change

    -2.7%
    BCLI price is down -2.7% today

    Price YTD change

    -68.28%
    BCLI price is down -68.28% since January 1st

    Price 1-year change

    -85.88%
    BCLI price is down -85.88% year-on-year

    Price 3-year change

    -98.12%
    BCLI price is down -98.12% over the past 3 years

    Price Range

    Price All-time high

    $787.50
    BCLI price is currently -99.91% below its historical high of $787.50

    Price 3-year low

    $0.59
    BCLI price is currently +22.03% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.72M
    BCLI market capitalization is $5.72 million

    Market cap 3-year change

    -93.88%
    BCLI market capitalization is down -93.88% over the past 3 years

    Market cap All-time high

    $559.69M
    BCLI market capitalization is currently -98.98% below its historical high of $559.69 million

    Market cap sector rank

    11.95%
    BCLI market capitalization is higher than 11.95% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +49.51%
    BCLI shares outstanding is up +49.51% year-on-year

    Shares Outstanding 3-Year Change

    +226.38%
    BCLI shares outstanding is up +226.38% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.74
    BCLI beta is 0.74

    200-day SMA

    $1.50
    BCLI price is currently -52.04% below its 200-day simple moving average

    50-day SMA

    $1.11
    BCLI price is currently -35.30% below its 50-day simple moving average

    RSI

    30.59
    BCLI 14-day relative strength index is 30.59

    Volume

    0.79
    BCLI 30-day relative volume is 0.79

    ATR

    $0.11
    BCLI average true range is $0.11

    10-day Historical Volatility

    158.11%
    BCLI 10-day historical volatility is 158.11%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    BCLI annual revenue value is unknown

    Revenue Analysts estimate

    -
    BCLI annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    BCLI annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    BCLI annual revenue is unknown

    EPS

    EPS

    -$2.31
    BCLI annual earnings per share is -$2.31

    EPS Analysts estimate

    -$1.60
    BCLI annual earnings per share is currently +44.38% higher than the consensus analysts' forecast

    EPS 1-year change

    +61.5%
    BCLI annual earnings per share is up +61.5% year-on-year

    EPS Sector rank

    37.04%
    BCLI annual earnings per share is higher than 37.04% of companies in Healthcare sector

    Profit

    Gross profit

    -
    BCLI annual gross profit value is unknown

    Gross margin

    -
    BCLI annual gross profit margin value is unknown

    Operating profit

    -$11.69M
    BCLI annual operating income is -$11.69 million

    Operating margin

    -
    BCLI annual operating profit margin value is unknown

    Net income

    -$11.62M
    BCLI annual net profit is -$11.62 million

    Net margin

    -
    BCLI annual net profit margin value is unknown

    Expenses

    Total expenses

    $11.69M
    BCLI annual total expenses is $11.69 million

    Operating expenses

    $11.69M
    BCLI annual total operating expenses is $11.69 million

    Cost of goods sold

    -
    BCLI annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $7.04M
    BCLI annual SGA is $7.04 million

    Depreciation and amortization

    $240.00K
    BCLI annual depreciation & amortization is $240.00 thousand

    Interest expense

    -
    BCLI annual interest expense value is unknown

    Income tax

    -
    BCLI annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$11.69M
    BCLI annual earnings before interest & taxes is -$11.69 million

    EBITDA

    -$11.45M
    BCLI annual EBITDA is -$11.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.83M
    BCLI annual total assets is $1.83 million

    Non current assets

    $1.45M
    BCLI annual long term assets is $1.45 million

    Current assets

    $385.00K
    BCLI annual total current assets is $385.00 thousand

    Cash and cash equivalents

    $187.00K
    BCLI annual cash & cash equivalents is $187.00 thousand

    Accounts receivable

    -
    BCLI annual accounts receivable value is unknown

    Inventory

    -
    BCLI annual inventory value is unknown

    Liabilities

    Total liabilities

    $9.60M
    BCLI annual total liabilities is $9.60 million

    Long term liabilities

    $618.00K
    BCLI annual total long term liabilities is $618.00 thousand

    Current liabilities

    $8.98M
    BCLI annual total current liabilities is $8.98 million

    Accounts payable

    $6.08M
    BCLI annual accounts payable is $6.08 million

    Debt

    Total debt

    $720.00K
    BCLI annual total debt is $720.00 thousand

    Total debt 1-year change

    -43.53%
    BCLI annual total debt is down -43.53% year-on-year

    Long term debt

    $171.00K
    BCLI annual long term debt is $171.00 thousand

    Short term debt

    $549.00K
    BCLI annual short term debt is $549.00 thousand

    Equity & Capital

    Shareholders equity

    -$7.76M
    BCLI annual stockholders equity is -$7.76 million

    Book value

    -$7.76M
    BCLI annual book value is -$7.76 million

    Retained earnings

    -$226.64M
    BCLI annual retained earnings is -$226.64 million

    Working capital

    -$8.59M
    BCLI annual working capital is -$8.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.09M
    BCLI annual cash flow from operations is -$9.09 million

    Cash from operations 1-year change

    +55.55%
    BCLI annual cash flow from operations is up +55.55% year-on-year

    Cash from investing

    $12.00K
    BCLI annual cash flow from investing activities is $12.00 thousand

    Cash from investing 1-year change

    -99.45%
    BCLI annual cash flow from investing activities is down -99.45% year-on-year

    Cash from financing

    $7.97M
    BCLI annual cash flow from financing activities is $7.97 million

    Cash from financing 1-year change

    -58.02%
    BCLI annual cash flow from financing activities is down -58.02% year-on-year

    CAPEX

    CAPEX

    -
    BCLI annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    BCLI annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$9.09M
    BCLI annual free cash flow is -$9.09 million

    Free cash flow 1-year change

    +55.59%
    BCLI annual free cash flow is up +55.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BCLI annual gross profit margin value is unknown

    Operating margin

    -
    BCLI annual operating profit margin value is unknown

    Net margin

    -
    BCLI annual net profit margin value is unknown

    ROA & ROE

    ROA

    -634.44%
    BCLI annual return on assets is -634.44%

    ROE

    149.70%
    BCLI annual return on equity is 149.70%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BCLI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BCLI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.77
    BCLI price to book ratio is -0.77

    PB ratio Sector rank

    10.26%
    BCLI price to book ratio is higher than 10.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BCLI price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BCLI price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $5.84M
    BCLI enterprise value is $5.84 million

    Enterprise value Sector rank

    17.43%
    BCLI enterprise value is higher than 17.43% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.48
    BCLI EV/EBITDA is -0.48

    EV/EBITDA Sector rank

    56.69%
    BCLI EV/EBITDA is higher than 56.69% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.04
    BCLI annual current ratio is 0.04

    Quick ratio

    -
    BCLI annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.09
    BCLI annual debt to equity ratio is -0.09

    Interest coverage ratio

    -
    BCLI annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BCLI piotroski f-score value is unknown

    Altman Z-Score

    -
    BCLI altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 11, 24 Maxim Group
    Buy
    Sep 28, 23 Maxim Group
    Hold
    Mar 31, 23 Maxim Group
    Buy
    Feb 5, 21 Maxim Group
    Buy
    May 15, 18 HC Wainwright & Co.
    Buy
    May 15, 18 H.C. Wainwright
    Buy
    Aug 17, 17 Maxim Group
    Buy

    Institutional Ownership

    Screeners with BCLI included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Brainstorm Cell Therapeutics Inc.?
    • Does Brainstorm Cell Therapeutics Inc. pay dividends?
    • What sector is Brainstorm Cell Therapeutics Inc. in?
    • What industry is Brainstorm Cell Therapeutics Inc. in?
    • What country is Brainstorm Cell Therapeutics Inc. based in?
    • When did Brainstorm Cell Therapeutics Inc. go public?
    • Is Brainstorm Cell Therapeutics Inc. in the S&P 500?
    • Is Brainstorm Cell Therapeutics Inc. in the NASDAQ 100?
    • Is Brainstorm Cell Therapeutics Inc. in the Dow Jones?
    • When was Brainstorm Cell Therapeutics Inc.'s last earnings report?
    • When does Brainstorm Cell Therapeutics Inc. report earnings?

    What is the ticker symbol for Brainstorm Cell Therapeutics Inc.?

    The ticker symbol for Brainstorm Cell Therapeutics Inc. is NASDAQ:BCLI

    Does Brainstorm Cell Therapeutics Inc. pay dividends?

    No, Brainstorm Cell Therapeutics Inc. does not pay dividends

    What sector is Brainstorm Cell Therapeutics Inc. in?

    Brainstorm Cell Therapeutics Inc. is in the Healthcare sector

    What industry is Brainstorm Cell Therapeutics Inc. in?

    Brainstorm Cell Therapeutics Inc. is in the Biotechnology industry

    What country is Brainstorm Cell Therapeutics Inc. based in?

    Brainstorm Cell Therapeutics Inc. is headquartered in United States

    When did Brainstorm Cell Therapeutics Inc. go public?

    Brainstorm Cell Therapeutics Inc.'s initial public offering (IPO) was on October 7, 2003

    Is Brainstorm Cell Therapeutics Inc. in the S&P 500?

    No, Brainstorm Cell Therapeutics Inc. is not included in the S&P 500 index

    Is Brainstorm Cell Therapeutics Inc. in the NASDAQ 100?

    No, Brainstorm Cell Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Brainstorm Cell Therapeutics Inc. in the Dow Jones?

    No, Brainstorm Cell Therapeutics Inc. is not included in the Dow Jones index

    When was Brainstorm Cell Therapeutics Inc.'s last earnings report?

    Brainstorm Cell Therapeutics Inc.'s most recent earnings report was on May 15, 2025

    When does Brainstorm Cell Therapeutics Inc. report earnings?

    The next expected earnings date for Brainstorm Cell Therapeutics Inc. is August 14, 2025
    On this page